我国基本药物制度实施过程中监管效率的探讨——基于成本收益分析的视角  

The Study on the Efficiency of Government Regulation in the Essential Drug System Implementation——Based on the Perspective of the Cost-benefit Analysis

作　　者：申俊龙[1] 王高玲[1] 陈美婕[1] 

机构地区：[1]南京中医药大学经贸管理学院,江苏南京210046

出　　处：《南京中医药大学学报（社会科学版）》2012年第3期174-179,共6页Journal of Nanjing University of Traditional Chinese Medicine(Social Science Edition)

基　　金：江苏省社会科学基金项目(11GLD019);江苏省高校哲学社会科学基金项目(2011SJB630045);江苏省教育厅高校"青蓝工程"资助项目(2008)

摘　　要：从成本收益分析的角度,对我国基本药物制度实施过程中政府监管效率的现状进行分析,探讨提高政府监管效率的关键点,进而提出健全监管法律法规、建立有效的多部门协调机制、加快监管的信息化建设等建议,促进基本药物制度实施过程中政府监管效率的提高。The current situation of the efficiency of government regulation in the essential medicine system implementation was analyzed using the cost-benefit analysis.The keys to the improvement of government regulation efficiency was explored in order to put forward suggestions for perfecting regulatory laws and regulations,establishing the effective multi-sectoral coordination mechanism and speeding up the information construction of regulation to promote the efficiency of government regulation for essential medicine system.

关 键 词：基本药物制度 政府监管 监管效率 成本收益分析 

分 类 号：R197.1[医药卫生—卫生事业管理]